Update: Cancer Immunotherapy Biotech Files for Insolvency
Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in…
December 6, 2019 - 2 minutes
Mologen
10 Biotech Companies in Berlin You Should Know
The vibrant startup scene of the German capital has attracted many biotechs to make it…
September 10, 2018 - 6 minutes
Say Hello to the Top 14 Entrepreneurial Women in European Biotech
Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting…
March 8, 2018 - 8 minutes
The German CEO Pushing for an Immunotherapy to Treat Cancer and HIV
Mariola Söhngen, CEO of Mologen, discusses biotech entrepreneurship in Germany and her company's unique immunotherapy…
October 23, 2017 - 8 minutes
The 10 Most Innovative HIV Treatments to Defeat AIDS
This infographic gathers 10 of the best HIV treatments in Europe's pipeline that will help…
September 13, 2017 - 1 minute
UPDATE: More Promising Results from Mologen’s New HIV Therapy
Update (17/02/2017): Mologen has announced more positive data for lefitolimod in HIV, as the Danish Aarhus…
February 17, 2017 - 2 minutes
Mologen Joins the Rapidly Growing List of EU Partners with the No#1 US Cancer Hospital
MD Anderson (US) and the Berlin Biotech Mologen (Germany) have now partnered on for an Immuno-Oncology program fighting…
January 21, 2016 - 2 minutes
Biotech of the week: Mologen, the Largest Publicly-listed Biotech of Berlin
This week, we're leaving Paris and heading East to a city that's 9 times bigger than…
October 16, 2015 - 2 minutes
